Berkley W R Corp lessened its holdings in shares of Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Free Report) by 69.2% in the second quarter, according to its most recent filing with the SEC. The firm owned 99,358 shares of the company’s stock after selling 223,332 shares during the quarter. Berkley W R Corp owned about 1.77% of Bellevue Life Sciences Acquisition worth $1,069,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in the business. Warberg Asset Management LLC boosted its position in Bellevue Life Sciences Acquisition by 47.1% during the 2nd quarter. Warberg Asset Management LLC now owns 39,781 shares of the company’s stock worth $429,000 after acquiring an additional 12,741 shares during the period. K2 Principal Fund L.P. acquired a new stake in shares of Bellevue Life Sciences Acquisition during the first quarter worth $358,000. Condor Capital Management acquired a new stake in shares of Bellevue Life Sciences Acquisition during the fourth quarter worth $121,000. Finally, Clear Street LLC raised its position in Bellevue Life Sciences Acquisition by 6,942.6% during the second quarter. Clear Street LLC now owns 8,592 shares of the company’s stock valued at $92,000 after buying an additional 8,470 shares during the period. Institutional investors and hedge funds own 55.30% of the company’s stock.
Bellevue Life Sciences Acquisition Price Performance
NASDAQ:BLAC opened at $10.89 on Tuesday. Bellevue Life Sciences Acquisition Corp. has a 1-year low of $10.39 and a 1-year high of $11.60. The business’s fifty day moving average price is $10.85 and its 200 day moving average price is $10.77.
Bellevue Life Sciences Acquisition Profile
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington.
Further Reading
- Five stocks we like better than Bellevue Life Sciences Acquisition
- Comparing and Trading High PE Ratio Stocks
- Don’t Overlook Mosaic’s Challenges—They Might Spark Opportunity
- How Can Investors Benefit From After-Hours Trading
- 4 Reasons GlobalFoundries Could Be a Big Winner After Recent Lows
- What Are Dividend Contenders? Investing in Dividend Contenders
- The Average 401k Balance by Age Explained
Want to see what other hedge funds are holding BLAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Free Report).
Receive News & Ratings for Bellevue Life Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
